Seguir
Tesa Severson
Tesa Severson
Dirección de correo verificada de nki.nl
Título
Citado por
Citado por
Año
Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin
RD Morin, NA Johnson, TM Severson, AJ Mungall, J An, R Goya, JE Paul, ...
Nature genetics 42 (2), 181-185, 2010
20092010
Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma
RD Morin, M Mendez-Lago, AJ Mungall, R Goya, KL Mungall, RD Corbett, ...
Nature 476 (7360), 298-303, 2011
19462011
Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution
SP Shah, RD Morin, J Khattra, L Prentice, T Pugh, A Burleigh, A Delaney, ...
Nature 461 (7265), 809-813, 2009
13432009
Acquired TNFRSF14 Mutations in Follicular Lymphoma Are Associated with Worse Prognosis
KJJ Cheung, NA Johnson, JG Affleck, T Severson, C Steidl, S Ben-Neriah, ...
Cancer research 70 (22), 9166-9174, 2010
2222010
Prostate cancer reactivates developmental epigenomic programs during metastatic progression
MM Pomerantz, X Qiu, Y Zhu, DY Takeda, W Pan, SC Baca, A Gusev, ...
Nature genetics 52 (8), 790-799, 2020
2112020
Integration of genomic, transcriptomic and proteomic data identifies two biologically distinct subtypes of invasive lobular breast cancer
M Michaut, SF Chin, I Majewski, TM Severson, T Bismeijer, L De Koning, ...
Scientific reports 6 (1), 1-13, 2016
2052016
Evolution of an adenocarcinoma in response to selection by targeted kinase inhibitors
SJM Jones, J Laskin, YY Li, OL Griffith, J An, M Bilenky, YS Butterfield, ...
Genome biology 11, 1-12, 2010
2052010
CD4+ T cell help creates memory CD8+ T cells with innate and help-independent recall capacities
T Ahrends, J Busselaar, TM Severson, N Bąbała, E de Vries, A Bovens, ...
Nature communications 10 (1), 5531, 2019
1292019
Assessment of PD-L1 expression across breast cancer molecular subtypes, in relation to mutation rate, BRCA1-like status, tumor-infiltrating immune cells and survival
M Sobral-Leite, K Van de Vijver, M Michaut, R van der Linden, ...
Oncoimmunology 7 (12), e1509820, 2018
1212018
Evidence for archaic Asian ancestry on the human X chromosome.
HMF Garrigan D, Mobasher Z, Severson T, Wilder JA
Mol Biol Evol 22 (22), 189-92, 2005
1212005
A novel DNA sequence database for analyzing human demographic history
HMF Wall JD, Cox MP, Mendez FL, Woerner A, Severson T
Genome Research 18 (8), 1354-61, 2008
1072008
ARID1A mutation sensitizes most ovarian clear cell carcinomas to BET inhibitors
K Berns, JJ Caumanns, EM Hijmans, AMC Gennissen, TM Severson, ...
Oncogene 37 (33), 4611-4625, 2018
1052018
BRCA1-like signature in triple negative breast cancer: Molecular and clinical characterization reveals subgroups with therapeutic potential.
T Severson, J Peeters, I Majewski, M Magali, A Bosma, S Philip, ...
Molecular Oncology 9, 1528-1538, 2015
872015
The circadian cryptochrome, CRY1, is a pro-tumorigenic factor that rhythmically modulates DNA repair
AA Shafi, CM McNair, JJ McCann, M Alshalalfa, A Shostak, TM Severson, ...
Nature communications 12 (1), 401, 2021
832021
The BRCA1ness signature is associated significantly with response to PARP inhibitor treatment versus control in the I-SPY 2 randomized neoadjuvant setting
TM Severson, DM Wolf, C Yau, J Peeters, D Wehkam, PC Schouten, ...
Breast Cancer Research 19, 1-9, 2017
812017
PIK3CA mutations, phosphatase and tensin homolog, human epidermal growth factor receptor 2, and insulin-like growth factor 1 receptor and adjuvant tamoxifen …
K Beelen, M Opdam, TM Severson, RHT Koornstra, AD Vincent, ...
Breast Cancer Research 16, 1-10, 2014
772014
Hypomorphic temperature-sensitive alleles of NSDHL cause CK syndrome
KW McLarren, TM Severson, C du Souich, DW Stockton, LE Kratz, ...
The American Journal of Human Genetics 87 (6), 905-914, 2010
772010
Noncoding mutations target cis-regulatory elements of the FOXA1 plexus in prostate cancer
S Zhou, JR Hawley, F Soares, G Grillo, M Teng, SA Madani Tonekaboni, ...
Nature communications 11 (1), 441, 2020
732020
DNA repair deficiency biomarkers and the 70-gene ultra-high risk signature as predictors of veliparib/carboplatin response in the I-SPY 2 breast cancer trial
DM Wolf, C Yau, A Sanil, A Glas, E Petricoin, J Wulfkuhle, TM Severson, ...
NPJ breast cancer 3 (1), 31, 2017
732017
Characterizing steroid hormone receptor chromatin binding landscapes in male and female breast cancer
TM Severson, Y Kim, SEP Joosten, K Schuurman, P Van Der Groep, ...
Nature communications 9 (1), 482, 2018
702018
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20